Ligand Pharmaceuticals | LGND - Ebit





Ebit Alterar Data
Agenus USD 14.4M 19.26M 2025-12
Amgen USD 3.83B 130M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -141.26M 182.07M 2026-03
Baxter International USD 66M 280.2M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Enviri Corporation USD -35.28M 61.58M 2025-12
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -200.28M 49.43M 2026-03
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -118M 97M 2026-03
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
Ligand Pharmaceuticals USD 60.33M 1.76M 2026-03
MacroGenics USD -12.1M 32.26M 2025-12
Merck USD -1.88B 8.12B 2026-03
Pacira USD 4.62M 1.43M 2026-03
Pfizer USD 4.99B 340M 2026-03
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Veracyte USD 19.08M 5.55M 2026-03